2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10876):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-A0009S
    Galanthamine-d3 hydrobromide
    Galanthamine-d3 (hydrobromide) is deuterium labeled Galanthamine (hydrobromide). Galanthamine hydrobromide (Galantamine hydrobromide) is a selective, reversible, competitive, alkaloid AChE inhibitor, with an IC50 of 0.35 μM. Galanthamine hydrobromide is a potent allosteric potentiating ligand (APL) of human α3β4, α4β2, α6β4 nicotinic receptors ( nAChRs). Galanthamine hydrobromide is developed for the research of Alzheimer's disease (AD).
    Galanthamine-d<sub>3</sub> hydrobromide
  • HY-A0251AS
    Cefpodoxime proxetil EP impurity A-d3 sodium
    Cefpodoxime-d3 (sodium) is deuterium labeled Cefpodoxime sodium.
    Cefpodoxime proxetil EP impurity A-d<sub>3</sub> sodium
  • HY-W715652
    2-Chloropyrimidine-4,5,6-d3
    2-Chloropyrimidine-4,5,6-d3 is the deuterium labeled 2-Chloropyrimidine (HY-Y0713).
    2-Chloropyrimidine-4,5,6-d<sub>3</sub>
  • HY-W709982
    12-Deoxy roxithromycin-d7
    12-Deoxy roxithromycin-d7 (Roxithromycin impurity H-d7) is the deuterium labeled 12-Deoxy roxithromycin.
    12-Deoxy roxithromycin-d<sub>7</sub>
  • HY-136820S1
    Taurultam-d2 hydrochloride
    Taurultam-d2 (hydrochloride) is deuterium labeled Taurultam.
    Taurultam-d<sub>2</sub> hydrochloride
  • HY-78726S
    Fosamprenavir-d4
    Fosamprenavir-d4 is the Deuterium-labeled Fosamprenavir (HY-78726). Fosamprenavir is an orally active inhibitor targeting HIV-1 protease and is a prodrug of Amprenavir (HY-17430). Fosamprenavir is hydrolyzed into Amprenavir (VX-478) by cell phosphatases in the intestinal epithelium. Amprenavir binds to the active site of HIV-1 protease, preventing the processing of viral gag and gag-pol polyprotein precursors, thereby inhibiting the formation of mature infectious virus particles and exerting anti-HIV-1 infection activity. Fosamprenavir can be used for the study of human immunodeficiency virus (HIV-1) infection.
    Fosamprenavir-d<sub>4</sub>
  • HY-W727757
    Pristanic acid-d6 (>90%)
    Pristanic acid-d6 (>90%) is the deuterium labeled Pristanic acid (HY-113024). Pristanic acid is an endogenous metabolite present in Blood that can be used for the research of Alpha Methylacyl CoA Racemase Deficiency and Zellweger Syndrome.
    Pristanic acid-d<sub>6</sub> (>90%)
  • HY-B0114S1
    Oxcarbazepine-d4-1
    Oxcarbazepine-d4-1 is deuterium labeled Oxcarbazepine. Oxcarbazepine is a sodium channel blocker. Oxcarbazepine significantly inhibits glioblastoma cell growth and induces apoptosis or G2/M arrest in glioblastoma cell lines. Anti-cancer and anticonvulsant effects.
    Oxcarbazepine-d<sub>4</sub>-1
  • HY-128383S1
    1-Methylpyrrolidine-d3
    1-Methylpyrrolidine-d3 is the deuterium labeled 1-Methylpyrrolidine (HY-128383). 1-Methylpyrrolidine is a methylated pyrrolidine, and cation with thermal-origin negative nonlinear optical (self-defocusing) properties.
    1-Methylpyrrolidine-d<sub>3</sub>
  • HY-W745177
    Methotrexate-d3
    Methotrexate-d3 Pentaglutamate Trifluoroacetate is the deuterium labeled Methotrexate Pentaglutamate Trifluoroacetate.
    Methotrexate-d<sub>3</sub>
  • HY-163313S
    Tyk2-IN-19-d6
    Tyk2-IN-19-d6 (compound 15) is the deuterium labeled Tyk2-IN-19 (HY-163313).
    Tyk2-IN-19-d<sub>6</sub>
  • HY-117281S1
    Moexipril-d3
    Moexipril-d3 is deuterated labeled Moexipril (HY-117281). Moexipril is an orally active inhibitor of angiotensin-converting enzyme (ACE), and becomes effective by being hydrolyzed to moexiprila hydrochloride. Moexipril exhibits antihypertensive and neuroprotective effects-.
    Moexipril-d<sub>3</sub>
  • HY-A0042S2
    Rufinamide-15N,d2-1
    Rufinamide-15N,d2-1 (CGP 33101-15N,d2-1) is 15N- and deuterium-labeled Rufinamide (HY-A0042).Rufinamide (CGP 33101) is an orally active antiepileptic compound that inhibits Na+ current activation, inhibits neuronal hyperexcitability, and has anticonvulsant effects. Rufinamide is used in the study of Lennox-Gastaut syndrome.
    Rufinamide-<sup>15</sup>N,d<sub>2</sub>-1
  • HY-150871S
    Uridine 5'-triphosphate-d7 ammonium
    Uridine 5'-triphosphate-d7 (ammonium) is the deuterium labeled Uridine 5'-triphosphate ammonium.
    Uridine 5'-triphosphate-d<sub>7</sub> ammonium
  • HY-W777622
    ent-Calindol amide-13C
    ent-Calindol amide-13C is the 13C-labeled ent-Calindol Amide (HY-W740666).
    ent-Calindol amide-<sup>13</sup>C
  • HY-Y0860S
    1,6-Dibromo-n-hexane-d12
    1,6-Dibromo-n-hexane-d12 is the deuterium labeled 1,6-Dibromo-n-hexane.
    1,6-Dibromo-n-hexane-d<sub>12</sub>
  • HY-167595S
    C18:0-d7 GD3 Ceramide (d18:1/18:0-d7)
    C18:0-d7 GD3 Ceramide (d18:1/18:0-d7) is deuterium labeled C18:0 GD3 Ceramide (d18:1/18:0).
    C18:0-d<sub>7</sub> GD3 Ceramide (d18:1/18:0-d<sub>7</sub>)
  • HY-143961S
    Givinostat impurity 5-d4
    Givinostat impurity 5-d4 is the deuterium labeled Givinostat impurity 5.
    Givinostat impurity 5-d<sub>4</sub>
  • HY-151877S
    Ethyl N-n-Butyl-d9-carbamate
    Ethyl N-n-Butyl-d9-carbamate is the deuterium labeled Ethyl N-n-Butyl-carbamate.
    Ethyl N-n-Butyl-d<sub>9</sub>-carbamate
  • HY-79096S2
    BOC-L-phenylalanine-d8
    BOC-L-phenylalanine-d8 is the deuterium labeled BOC-L-phenylalanine (HY-79096). Boc-L-phenylalanine is a Boc-protected L-phenylalanine that can be used in the synthesis of other active compounds. Boc-L-phenylalanine is also a capping agent.
    BOC-L-phenylalanine-d<sub>8</sub>